ArticleAssessment of Cytotoxicity and Genotoxicity in Patients with Rheumatoid Arthritis and its Relation to Disease Activity and Medications
ArticleAssessment of Cytotoxicity and Genotoxicity in Patients with Rheumatoid Arthritis and its Relation to Disease Activity and Medications
ArticleInterleukin-10, Interleukin- 16 and Interferon-γ in serum of patients with rheumatoid arthritis and correlation with disease activity
ArticleInterleukin-10, Interleukin- 16 and Interferon-γ in serum of patients with rheumatoid arthritis and correlation with disease activity
ArticleClinical and functional outcomes of Rheumatoid Arthritis with analysis of disease characteristics
ArticleClinical and functional outcomes of Rheumatoid Arthritis with analysis of disease characteristics
ArticleSerum Levels Of Interleukin–12 And Tumour Necrosis Factor– In Patients With Active And Inactive Rheumatoid Arthritis
ArticleSerum Levels Of Interleukin–12 And Tumour Necrosis Factor– In Patients With Active And Inactive Rheumatoid Arthritis
ArticleIndicators of Biochemistry and Hematology in Patients with Rheumatoid Arthritis Carrying the HLA-DRB1*04 or HLA-DRB1*10 Gene Variants
ArticleIndicators of Biochemistry and Hematology in Patients with Rheumatoid Arthritis Carrying the HLA-DRB1*04 or HLA-DRB1*10 Gene Variants
ArticlePathogenic Role of Interlukin-23(IL-23) in Rheumatoid Arthritis Patients; its Relation to Disease Activity
ArticlePathogenic Role of Interlukin-23(IL-23) in Rheumatoid Arthritis Patients; its Relation to Disease Activity
ArticleSerum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity
ArticleSerum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity